Part 1 – New 2019 CPT Codes: Integumentary System
RHIA, CDIP, CCS, CCS‑P, CIRCC
Executive Director Of Education
AHIMA‑Approved ICD‑10‑CM/PCS Trainer and Ambassador
This is Part 1 of a five part series on the new 2019 CPT codes. In this series we will explore the CPT changes for FY2019 and include examples to help the coder understand the new codes. There were 15 new integumentary CPT codes added with 3 deletions and 1 revision.
Fine Needle Aspiration Biopsies
Code 10022, FNA with imaging guidance was deleted. One revised and 5 new codes now identify fine needle biopsy by type of imaging guidance. The codes are as follows:
10021 Fine needle aspiration biopsy, without imaging guidance, first lesion
#+10004 each additional lesion (list in addition to primary)
10005 Fine needle aspiration biopsy, including ultrasound guidance, first lesion
#+10006 each additional lesion (list in addition to primary)
10007 Fine needle aspiration biopsy, including fluoroscopic guidance, first lesion
#+10008 each additional lesion (list in addition to primary)
10009 Fine needle aspiration biopsy, including CT guidance, first lesion
#+10010 each additional lesion (list in addition to primary)
10011 Fine needle aspiration biopsy, including MR guidance, first lesion
#+10012 each additional lesion (list in addition to primary)
New notes and explanations are at the beginning of subsection.
- A fine needle aspiration (FNA) biopsy is performed when material is aspirated with a fine needle and the cells are examined cytologically.
- A CORE needle biopsy is typically performed with a larger bore needle to obtain a core sample of tissue for histopathologic evaluation.
If two different biopsy using different imaging modalities on different lesions, use the primary code for each one with -59 on second.
If FNA and CORE biopsies are done on the SAME lesion, same session, same day, same type of imaging guidance, do NOT separately report the imaging guidance for the CORE biopsy with modifier -59:
10007- FNA biopsy including fluoroscopic imaging first lesion
19100-59 – Biopsy of breast; percutaneous, needle core, not using imaging guidance (separate
Report the core biopsy code WITHOUT guidance. The same guidance should NOT be reported twice.
If FNA and CORE biopsies are done on SEPARATE lesions, same session, same day, same type of imaging guidance, then report both types of biopsies with imaging guidance, with modifier -59 on second.
Six new codes were created to identify differing types of skin biopsies. The codes along with helpful descriptions are below:
11102 Tangential biopsy of skin (eg, shave, scoop, saucerize, curette) single lesion (Tangential means along a tangent, diverging from previous line)
+11103 each separate/additional lesion (list in addition to primary)
11104 Punch biopsy of skin (including simple closure, when performed); single lesion (uses a punch tool)
+11105 each separate/additional lesion (list in addition to primary)
11106 Incisional biopsy of skin (including simple closure, when performed); single lesion (uses a sharp blade) (most complicated of the three)
+11107 each separate/additional lesion (list in addition to primary)
The coder may have to query the MD if the type of biopsy is not well documented. A punch biopsy uses a punch tool but beware of “punch excision,” where a tool is used to remove lesion with margins.
Do not confuse “tangential” biopsy with shave removal of lesion, 11300-11313. In a biopsy only a portion is shaved off. In shave removal, the entire lesion is removed.
The add on codes can be used with a different primary code if there is more than one lesion. The primary codes are hierarchical with incisional being the most intense, followed by punch and then by the tangential. For example, for 1 incisional biopsy, 1 tangential biopsy and 1 punch biopsy is coded 11106 x1, 11103 x 1 and 11105 x 1. Notice that the incisional biopsy primary code is used, and the add on code for the other two are used.
Other CPT Codes Involving Integument
There are two new codes for ESWT for skin wounds:
0512T Extracorporeal shock wave for integumentary wound healing, high energy, including topical application and dressing care, initial wound
+0513T each additional wound (list in addition to primary)
ESWT treats complex skin and soft tissue wounds without disrupting bone. The coder will see “shock-count delivery” and this is determined by wound volume and comorbidities. High energy shock impulses are delivered to the wound and at least 1 cm around the existing wound.
In Part 2, we will discuss musculoskeletal code changes.
The information contained in this post is valid at the time of posting. Viewers are encouraged to research subsequent official guidance in the areas associated with the topic as they can change rapidly.
In the past, there had been an Excludes1 note at I46.- Cardiac arrest that excluded R57.0, Cardiac shock. HIA had also received a letter from AHA on a case in the past that had stated that only I46.- Cardiac arrest would be coded if both were documented. In addition, the Third Quarter Coding Clinic page 26 had a similar case that asked if both could be coded, and AHA had instructed that only I46.9, cardiac arrest, cause unspecified would be coded if both were documented and that the CDC would be looking at possible revision to the Excludes1 note.
A higher CMI corresponds to increased consumption of resources and increased cost of patient care, resulting in increased reimbursement to the facility from government and private payers, like CMS. We know that documentation directly impacts coding.
Lately we have seen several cases where the endarterectomy was assigned along with the coronary artery bypass (CABG) procedure when being performed on the same vessel to facilitate the CABG. A coronary artery endarterectomy is not always performed during a CABG procedure, so when it is performed it becomes confusing as to whether to code it separately or not.
Assign code Z20.828, “Contact with and (suspected) exposure to other viral communicable diseases” for all patients who are tested for COVID-19 and the results are negative, regardless of symptoms, no symptoms, exposure or not as we are in a pandemic.
The Centers for Medicare & Medicaid Services (CMS) announced new procedure codes for treatments of COVID-19 – effective as of August 1, 2020. Among the new codes are Section X New Technology codes for the introduction or infusion of therapeutics including Remdesivir, Sarilumab, Tocilizumab, transfusion of convalescent plasma, as well as introduction of any other or new therapeutic substances for the treatment of COVID-19.
One common element in many value-based programs is risk adjustment using Hierarchical Condition Categories (HCCs) to create a Risk Adjustment Factor (RAF) score. This method ranks diagnoses into categories that represent conditions with similar cost patterns.
Why are so many AKI records being denied? It’s hard to give one answer for why so many AKI records are being denied lately, but most appear to be due to the multiple sets of criteria available for use in determining if a patient has AKI, as well as physician documentation. As stated in Part 3 of this series, there are three main criteria/classifications used to diagnose AKI.
In previous parts of this series we looked at the definitions of AKI/ARF, causes, coding and sequencing, and the common clinical indicators that patients present with that are diagnosed with this condition. In Part 4, we will look at the documentation that should be present to report the diagnosis without fear of denial, as well as when a query is needed to clarify the diagnosis.
If the facility does a COVID-19 test, and test is negative, do I need a diagnosis code. The answer is yes, you will report a Z-code. The Z-code depends on the record documentation and circumstances of testing. For any patient receiving a COVID-19 test, if negative, there MUST e a Z-code to describe why the test was taken. (Test negative for COVID-19 and MD does not override negative results).
In the first parts of this series we looked at definitions of AKI/ARF, causes, coding and sequencing. In Part 3, we will look at what clinical indicators would possibly be present to support the diagnosis of AKI/ARF.
The FY2021 IPPS Proposed Rule is out and here are some highlights from it regarding ICD-10 Code proposals. We will know if these changes are permanent after the public comment period is over on July 10, 2020 and CMS prepares the Final Rule, usually out by August 1.
As discussed in Part 1 of this series, AKI/ARF is a common diagnosis that coders see daily. In Part 2, we are going to focus on the different types/specificity of AKI/ARF. We’ll learn what they mean, as well as how to code the diagnosis.
This is part 1 in a series focused on coding of acute kidney injury (AKI) and/or acute renal failure (ARF). AKI/ARF is reported often, but is also one of the most common diagnosis found in denials.
With the proliferation of COVID-19 cases, we thought we would put together a quick reference listing of some of the common scenarios that coders have asked about. As with all coding, coders should follow Official Guidelines for Coding and Reporting and the COVD-19 Frequently Asked Questions document by the AHA.
Effective March 1, Medicare will pay physicians for telehealth services at the same rate as in-person visits for all diagnoses, not just services related to COVID-19. This great for providers whose patients are reluctant to visit the office.
The biggest reasons why some hospital systems are moving to single path coding is to eliminate duplicative processes and to optimize productivity. In addition, costs are reduced when only one coder “touches” the record and completes both types of coding.
Effective with 4/1/2020 discharges, ICD-10-CM code U07.0 is used to report vaping -related disorders. ICD-10-CM code U07.0 (vaping related disorder) should be used when documentation supports that the patient has a lung-related disorder from vaping. This code is found in the new ICD-10-CM Chapter 22. U07.0 will be in listed in the ICD-10-CM manual under a new section: Provisional assignment of new disease of uncertain etiology or emergency use.
The US government and public-health officials are urging consumers to utilize telemedicine for remote treatment, fill prescriptions and get medical attention during the new coronavirus pandemic. The goal is to keep people with symptoms at home and to practice social distancing if their condition doesn’t warrant more intensive hospital care.
Coronavirus: Tips for working from home. Companies around the world have told their employees to stay home and work remotely. Whether you’re a new to this concept or a work from home veteran, here’s some tips to staying productive from our #HIAfamily.
This is the final part of a three part series in which we address how coders can better interact with Clinical Documentation Improvement (CDI) professionals. In this part, we provide an actual example of an effective communication response to CDI.
This is part two of a three part series in which we address how coders can better interact with Clinical Documentation Improvement (CDI) professionals. In this part, we discuss mismatches and how to best go about resolving them. In part three we will provide a case example of best practice interaction.
This is part one of a three part series in which we address how coders can better interact with Clinical Documentation Integrity (CDI) professionals. Many times these departments are separate and the remote environment makes it difficult to interact efficiently between the two departments. In part one, we will discuss the history and objectives of CDI so the coder has a better understanding of CDI’s role.
One reason that coders should report chronic conditions (including history and status codes) on outpatient records is the HCC’s—Hierarchical Condition Categories. The quick and easy explanation of what HCC’s are is each HCC is mapped to certain ICD-10-CM codes or code ranges. HCC coding is designed to estimate future health care costs for patients.
For Part 4 of this 5-part series, we will look at Chapter 10 within ICD-10-CM—J00-J99—Diseases of the Respiratory System. There is no possible way to include every guideline or coding reference for this chapter, but here are some of the most common issues.
For Part 3 of this 5 part series, we will look at Chapter 9 within ICD-10-CM—I00-I99—Diseases of the Circulatory System. This chapter contains so many of the everyday diagnoses that we code such as hypertension, heart disease and stroke.
For Part 2 of this 5-part series, we will look at Chapter 1 within ICD-10-CM—A00-B99—Certain Infectious and Parasitic Diseases. There is no possible way to include every guideline or coding reference for this chapter, but here are some of the most common issues.
For Part 1 of this 5-part series, we will look at Chapter 21 within ICD-10-CM—Z00-Z99—Factors influencing health status and contact with health services. There is no possible way to include every guideline or coding reference for this chapter, but I’ll do my best to touch on some off the most common issues.
The HIM world has been buzzing recently with discussion of “Social Determinants of Health” and coded data. What does this mean for coders and the HIM field?
In response to the recent occurrences of vaping related disorders and in consultation with the World Health Organization (WHO) Framework Convention on Tobacco Control, the WHO Family of International Classifications (WHOFIC) Network Classification and Statistics Advisory Committee (CSAC) was convened to discuss a diagnosis code for vaping related illness for immediate use.